Apolipoprotein E and functional recovery from brain injury following postacute rehabilitation
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Objective: APOE ε4 has been associated with late-onset familial and sporadic AD and delayed recovery from head injury. The authors examined the relationship between functional recovery of patients with head injury and the APOE alleles.
Methods: Thirty-one patients with head injury who had completed the Acute Neurorehabilitation Program at Helen Hayes Hospital were evaluated for presence of APOE ε4 and assessed for recovery based on Functional Independence Measures (FIM).
Results: Analysis of covariance (using coma days as the covariate to control for differences in initial severity of injury between subjects with and without APOE ε4) revealed a significant difference for both total FIM and motor FIM scores between the subjects with and without APOE ε4. Specifically, there were lower scores for total FIM (df = 30; F = 3.341; p = 0.05) and motor FIM (df = 30; F = 4.189; p = 0.026) in APOE ε4 carriers. No difference was found for the cognitive portion of the FIM.
Conclusions: The data suggest that the presence of the lipoprotein APOE ε4 adversely affects rehabilitation outcome for traumatic brain injury survivors.–1539
- Received April 14, 2000.
- Accepted July 20, 2000.
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Efficacy of Ubrogepant in the Acute Treatment of Migraine With Mild Pain vs Moderate or Severe Pain
Dr. Kathleen Digre and Dr. Kendra Pham
► Watch
Related Articles
- No related articles found.
Alert Me
Recommended articles
-
Articles
Hippocampal volume, brain atrophy, and APOE genotype after traumatic brain injuryH. Isoniemi, T. Kurki, O. Tenovuo et al.Neurology, September 11, 2006 -
Articles
Apolipoprotein E-ε4 genotype predicts a poor outcome in survivors of traumatic brain injuryG. Friedman, P. Froom, L. Sazbon et al.Neurology, January 01, 1999 -
Article
Effects of APOE ε4, age, and HIV on glial metabolites and cognitive deficitsLinda Chang, Caroline Jiang, Eric Cunningham et al.Neurology, May 21, 2014 -
Articles
Prediction of recovery of continuous memory after traumatic brain injuryD.T. Stuss, M.A. Binns, F.G. Carruth et al.Neurology, March 28, 2000